Search Results - "Sims, Cynthe"
-
1
Standardizing gene product nomenclature-a call to action
Published in Proceedings of the National Academy of Sciences - PNAS (19-01-2021)Get full text
Journal Article -
2
Opinion: Standardizing gene product nomenclature-a call to action
Published in Proceedings of the National Academy of Sciences - PNAS (19-01-2021)Get full text
Journal Article -
3
Reference Size Matching, Whole-Genome Amplification, and Fluorescent Labeling as a Method for Chromosomal Microarray Analysis of Clinically Actionable Copy Number Alterations in Formalin-Fixed, Paraffin-Embedded Tumor Tissue
Published in The Journal of molecular diagnostics : JMD (01-05-2018)“…Cancer genome copy number alterations (CNAs) assist clinicians in selecting targeted therapeutics. Solid tumor CNAs are most commonly evaluated in…”
Get full text
Journal Article -
4
Antibiotic Resistance in Bacteria: Novel Metalloenzyme Inhibitors
Published in Chemical biology & drug design (01-10-2009)“…β-Lactam antibiotics are among the most important drugs used to fight bacterial infection. Overuse and misuse of β-lactam antibiotics has caused the evolution…”
Get full text
Journal Article -
5
Standardizing gene product nomenclature—a call to action
Published in Proceedings of the National Academy of Sciences - PNAS (19-01-2021)Get full text
Journal Article -
6
Abstract P4-01-05: Circulating ensembles of tumor associated cells for detection of breast cancer
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Abstract Background: Mammographic screening for breast cancer offers the possibility of reducing morbidity and mortality from the disease but has economic and…”
Get full text
Journal Article -
7
Circulating ensembles of tumor‐associated cells: A redoubtable new systemic hallmark of cancer
Published in International journal of cancer (15-06-2020)“…Circulating ensembles of tumor‐associated cells (C‐ETACs) which comprise tumor emboli, immune cells and fibroblasts pose well‐recognized risks of thrombosis…”
Get full text
Journal Article -
8
Abstract A49: Viable circulating ensembles of tumor-associated cells persist in pretreated patients with solid organ cancers showing no radiologically detectable disease
Published in Clinical cancer research (01-06-2020)“…Abstract The success of treatment in solid organ cancers is ascertained by radiologic imaging as per standard-of-care protocol, with PET-CT being the modality…”
Get full text
Journal Article -
9
Abstract B15: Circulating tumor cells express tissue specific antigens in multiple cancers
Published in Clinical cancer research (01-06-2020)“…Abstract Definitive diagnosis of solid organ cancers is based on histopathologic analysis of tumor tissue obtained by invasive biopsies. However, invasive…”
Get full text
Journal Article -
10
Abstract B17: An mRNA signature that accurately discerns gliomas from healthy individuals
Published in Clinical cancer research (01-06-2020)“…Abstract Diagnosis of suspected cases of gliomas such as intracranial space-occupying lesions (ICSOLs) is based on histopathologic analysis of tumor tissue…”
Get full text
Journal Article -
11
Abstract B61: Encyclopedic noninvasive liquid biopsies for differential diagnosis in prostate cancer
Published in Clinical cancer research (01-06-2020)“…Abstract Differential diagnosis of prostatic adenocarcinomas is based on histopathologic analysis of tumor tissue obtained by transrectal ultrasound…”
Get full text
Journal Article -
12
Circulating ensembles of tumor-associated cells in genitourinary cancers
Published in Journal of clinical oncology (20-02-2020)“…Abstract only 718 Background: Detection of genitourinary cancers is based on histopathological analysis of tumor tissue obtained by invasive biopsies following…”
Get full text
Journal Article -
13
Abstract P6-10-11: In vitro chemo interrogation of viable circulating tumor associated cells from breast cancer patients
Published in Cancer research (Chicago, Ill.) (15-02-2020)“…Abstract Background: Chemoresistance in cancer cells is the underlying reason for treatment failure. Real-time monitoring of chemoresistance and response (CRR)…”
Get full text
Journal Article -
14
PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in gastroesophageal cancers
Published in Journal of clinical oncology (10-02-2020)“…Abstract only 29 Background: Selection of Immune Checkpoint Inhibitor (ICI) therapies in Gastroesophageal cancers are based on IHC based detection of PD-L1…”
Get full text
Journal Article -
15
PD-L1 profiling of circulating tumor cells for immune checkpoint inhibitor therapy in head and neck cancers
Published in Journal of clinical oncology (10-02-2020)“…Abstract only 36 Background: Selection of Immune Checkpoint Inhibitor (ICI) therapies in Head and Neck cancers are based on IHC based detection of PD-L1…”
Get full text
Journal Article -
16
Abstract PS4-36: Non-invasive evaluation of chemoresistance in breast cancers using circulating tumor associated cells
Published in Cancer research (Chicago, Ill.) (15-02-2021)“…Abstract Background: Despite the development of Checkpoint Inhibitor Treatments (Immunotherapy) and Targeted anticancer agents, cytotoxic (chemotherapy) agents…”
Get full text
Journal Article -
17
Circulating microtumors: A functional hallmark for cancer detection and management
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 3544 Background: There are presently no accepted non-invasive means for detection of cancers in asymptomatic individuals or suspected cases…”
Get full text
Journal Article -
18
Liquid biopsies to enable non-invasive real-time functional chemoresistance profiling in solid organ cancers
Published in Journal of clinical oncology (20-05-2020)“…Abstract only 3525 Background: Despite the development of targeted therapy agents and immune checkpoint inhibitors (ICI), cytotoxic anticancer agents remain…”
Get full text
Journal Article -
19
Multi-analyte liquid biopsies based treatment in advanced refractory cancers
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e15623 Background: Tumor tissue profiling following invasive biopsies is presently the standard approach for indication-based therapy management…”
Get full text
Journal Article -
20
Multi-analyte interrogation based treatment of advanced refractory cancers
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e15624 Background: Treatment of advanced refractory cancers face challenges in non-availability of systemic therapy regimens with evidenced…”
Get full text
Journal Article